Certara Appoints new Chief Marketing Officer, Sheila Rocchio Announcement Certara Appoints new Chief Marketing Officer, Sheila Rocchio Princeton, N.J., June 13, 2023 – Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today…CertaraJune 14, 2023
What’s New for SEND 2023 On-Demand Webinar What’s New for SEND 2023 This webinar will focus on several changes to the CDISC SEND standard that became active…CertaraJune 12, 2023
Certara Launches Version 8.4 of Phoenix™ Biosimulation Software for Drug Development Announcement Certara Launches Version 8.4 of Phoenix™ Biosimulation Software for Drug Development Latest updates demonstrate commitment to customers and market leadership of Phoenix Platform PRINCETON, N.J.— June…CertaraJune 12, 2023
Certara enhances CODEX Clinical Outcome Analytics Platform with AI Announcement Certara enhances CODEX Clinical Outcome Analytics Platform with AI Trial design and execution now accelerated by deep learning and data fabric capabilities. PRINCETON, NJ…CertaraJune 8, 2023
Unlocking Efficiency and Quality: What is New in Phoenix™ 8.4? On-Demand Webinar Unlocking Efficiency and Quality: What is New in Phoenix™ 8.4? Join us for an exclusive webinar as Certara introduces the highly anticipated version 8.4 of…CertaraJune 5, 2023
QSP Designer: Quantitative systems pharmacology modeling with modular biological process map notation and multiple language code generation Publication QSP Designer: Quantitative systems pharmacology modeling with modular biological process map notation and multiple language code generation Typical Quantitative Systems Pharmacology (QSP) workflows involve discussion of biology, supported by graphical diagrams, followed…CertaraMay 25, 2023
Dose Optimization: Getting it Right for Vulnerable Populations Press Coverage Dose Optimization: Getting it Right for Vulnerable Populations By: Justin Hay & Frank Engler Pandemics amplify existing strengths and vulnerabilities—not only highlighting who…CertaraMay 22, 2023
Japan’s Approach to Pediatric Drug Development: What You Need to Know Blog Japan’s Approach to Pediatric Drug Development: What You Need to Know Access to safe and effective medications is critical for pediatric patients, yet 60-70% of medicines…CertaraMay 22, 2023
Certara’s Synchrogenix Writer now enhanced with AI Layar Announcement Certara’s Synchrogenix Writer now enhanced with AI Layar Next generation automation for Medical Writers to streamline the creation of regulatory documents Certara is…CertaraMay 11, 2023
The Impact of the Inflation Reduction Act on Biosimilar Uptake Press Coverage The Impact of the Inflation Reduction Act on Biosimilar Uptake In an interview with HCPLive, Maximilian Vargas, PhD, MBA, vice president of the United States…CertaraMay 8, 2023